GlassScriptPhysician profile
Pamela S Sloop
NPI 1952442527
$4,506.22
in general payments reported to CMS, 2019-2025
37 companies · $973 in 2025
The $973 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,186 · 2022: $908 · 2023: $838 · 2024: $601 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,388 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.83 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,367.42 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $567.82 | 2021-2025 | Xifaxan, Trulance |
| Pfizer INC. | $326.04 | 2021-2025 | |
| Glaxosmithkline, LLC. | $220.23 | 2021-2023 | Trelegy Ellipta, Shingrix |
| Ardelyx, INC. | $187.93 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $153.49 | 2021-2025 | Wegovy |
| Avion Pharmaceuticals | $148.36 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.24 | 2022-2025 | |
| Astellas Pharma US INC | $116.43 | 2021-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $83.95 | 2021-2025 | Breztri |
| Amarin Pharma, INC. | $75.35 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.65 | 2021-2023 | Jardiance |
| Merz North America, INC. | $71.87 | 2023 | Xeomin |
| Otsuka America Pharmaceutical, INC. | $65.41 | 2024 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $65.33 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Sloop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.